MyAverix Finance MyAverix Finance

HM

Novo Nordisk A/S (NOV)

Novo Nordisk A/S (NOV) is listed on HM. As of 2026-05-24, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for NOV

P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

Novo Nordisk A/S (NOV) — FAQ

What is NOV's P/E ratio?

The price-to-earnings (P/E) ratio for Novo Nordisk A/S (NOV) is 18.00 (data as of 2026-05-24).

Does Novo Nordisk A/S pay a dividend?

Dividend yield is not available in the current snapshot for Novo Nordisk A/S (NOV). Check the MyAverix Finance app for the latest dividend data.

What exchange is NOV listed on?

NOV is listed on HM.

What is Novo Nordisk A/S's net margin?

Novo Nordisk A/S (NOV) reports a net margin of 0.0% (data as of 2026-05-24).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play